Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine
Eric Schafer, M.D.
Texas Children’s Cancer and Hematology Centers
1102 Bates Street, Suite 1570
Houston, TX 77030
Dr. Eric Schafer is a physician for the Leukemia Program at Texas Children’s Cancer Center.
M.D., Baylor College of Medicine
M.H.S., Johns Hopkins Bloomberg School of Public Health
Fellowship, Pediatric Hematology/Oncology, Johns Hopkins University / National Cancer Institute
Residency, Children’s Hospital of Philadelphia
American Board of Pediatrics
American Board of Pediatrics – Hematology/Oncology
Novel Therapies for Leukemia
American Academy of Pediatrics (AAP)
American Society of Hematology (ASH)
American Society of Pediatric Hematology/Oncology (ASPHO)
Children’s Oncology Group (COG)
Dr. Eric Schafer conducts research in the area of childhood leukemia. His major goals are to improve the outcome for MLL-r leukemias by developing therapies that target aberrant promoter hypermethylation. In addition, he is investigating the role of promoter hypermethylation in the biology of MLL-rearranged leukemia, and as a novel target for therapy. He also hopes to characterize the epigenetic profiles of the major subsets of childhood ALL and to develop epigenetically-targeted therapies to improve outcomes.
Dr. Schaffer is a recipient of the K12 Clinical Research Scholar Program Award. The program is designed to provide support for mentored clinical research training and career development for junior faculty dedicated to a career in clinical investigation.